Expertise in
7
conditions

Hirotsugu Sakamoto

Shimotsuke, JP 
Expertise in
7
conditions
Shimotsuke, JP 

Overview

Hirotsugu Sakamoto practices practicing medicine in Shimotsuke, Japan.

Sakamoto is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Peutz-Jeghers Syndrome, Intussusception in Children, Melasma, Endoscopy, and Colonoscopy.

They are actively involved in clinical research, co-authoring 276 peer reviewed articles and participating in 2 clinical trials.

Locations

Shimotsuke, Japan
Other Locations
Japan
Tochigi, Japan
Tokyo, Japan
Saitama, Japan
Tsukuba, Japan
Ami, 3000393, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 1 Less Clinical Trial

276 Total Publications

Mycophenolate Mofetil-induced Multiple Ileal Ulcerations in a Renal Transplant Recipient: Diagnostic Challenges and Management.
Mycophenolate Mofetil-induced Multiple Ileal Ulcerations in a Renal Transplant Recipient: Diagnostic Challenges and Management.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2025

Frequently Asked Questions about Hirotsugu Sakamoto

Is Hirotsugu Sakamoto a top-rated expert for Peutz-Jeghers Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Hirotsugu Sakamoto is classified as an Distinguished expert for Peutz-Jeghers Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hirotsugu Sakamoto participate in research or clinical trials?

Yes. Hirotsugu Sakamoto has published 276 articles and abstracts on conditions like Peutz-Jeghers Syndrome. You can view a list of Hirotsugu Sakamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sakamoto's expertise for a condition
ConditionClose
    View All 23 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile